Component
TrkA-dependent PC12 differentiation
Species, preparation, dose and limitations are retained on linked claims.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Erinacine C induced PC12 differentiation through TrkA and associated PLC-gamma, PI3K and ERK pathways.
Experimental context and source evidence
- dose
- Erinacine C with genetic and pharmacological inhibitors
- duration
- Differentiation assay
- evidence_access
- Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
- evidence_scope
- literature_reviewed; model-specific source-derived curation
- experimental_model
- PC12 cells and astrocytic reporter cells
- limitations
- The study supports pathway involvement but not direct binding, human exposure, or a clinical neuroregenerative effect.
- nutrient_topic
- Hericenones & Erinacines chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings. · Hericenones and erinacines
- organism
- PC12 cells and astrocytic reporter cells
- plain_language
- Erinacine C induced PC12 differentiation through TrkA and associated PLC-gamma, PI3K and ERK pathways.
- primary_references
- Erinacine C Activates Transcription from a Consensus ETS DNA Binding Site in Astrocytic Cells in Addition to NGF Induction. (2020). https://pubmed.ncbi.nlm.nih.gov/33066380/ DOI: 10.3390/biom10101440
- route
- In vitro
- tissue
- Neurotrophin-dependent differentiation
Hericenones & Erinacines: mechanism of action and interactions (2026-09-20) · lines 88–97
Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text. · supports · PC12 cells and astrocytic reporter cells · source_derived_draft · unverified_draft
## hericenones-erinacines-erinacine-c-trka Erinacine C induced PC12 differentiation through TrkA and associated PLC-gamma, PI3K and ERK pathways. Model/species: PC12 cells and astrocytic reporter cells Tissue/system: Neurotrophin-dependent differentiation Exposure: Erinacine C with genetic and pharmacological inhibitors Route: In vitro Duration: Differentiation assay Limits: The study supports pathway involvement but not direct binding, human exposure, or a clinical neuroregenerative effect. Primary reference: Erinacine C Activates Transcription from a Consensus ETS DNA Binding Site in Astrocytic Cells in Addition to NGF Induction. (2020). https://pubmed.ncbi.nlm.nih.gov/33066380/ DOI: 10.3390/biom10101440 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.